Halozyme (HALO) is up 11% to $50.99 in pre-market trading.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EVO:
- Halozyme withdraws proposal to acquire Evotec
- Halozyme withdraws proposal to acquire Evotec for EUR 11.00 per share in cash
- Spirit enters into bankruptcy proceedings, CVS names new directors: Morning Buzz
- Halozyme provides update on proposal to combine with Evotec
- Berkshire reveals stake in Domino’s, Alibaba reports mixed Q2: Morning Buzz
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue